-
1دورية أكاديمية
المؤلفون: McCrimmon, Rory J., Falla, Edel, Sha, Jo Zhou, Alsaleh, Abdul Jabbar Omar, Lew, Elisheva, Hudson, Richard, Baxter, Mike, Palmer, Karen
المصدر: McCrimmon , R J , Falla , E , Sha , J Z , Alsaleh , A J O , Lew , E , Hudson , R , Baxter , M & Palmer , K 2021 , ' Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK ' , Diabetes Therapy , vol. 12 , no. 12 , pp. 3217-3230 . https://doi.org/10.1007/s13300-021-01159-yTest
مصطلحات موضوعية: Cost-effectiveness, Cost-utility, Dulaglutide, GLP-1 receptor agonist, iDegLira, iGlarLixi, Liraglutide, Type 2 diabetes mellitus, United Kingdom, /dk/atira/pure/subjectarea/asjc/2700/2724, name=Internal Medicine, /dk/atira/pure/subjectarea/asjc/2700/2712, name=Endocrinology, Diabetes and Metabolism
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1007/s13300-021-01159-yTest
https://discovery.dundee.ac.uk/en/publications/9b18fb92-4700-472e-a7bd-cf9fda7c907eTest
https://discovery.dundee.ac.uk/ws/files/68966155/McCrimmon2021_Article_Cost_EffectivenessOfIGlarLixiI.pdfTest
http://www.scopus.com/inward/record.url?scp=85118320249&partnerID=8YFLogxKTest -
2دورية أكاديمية
المؤلفون: Willard, Francis S., Douros, Jonathan D., Gabe, Maria, Showalter, Aaron D., Wainscott, David B., Suter, Todd M., Capozzi, Megan E., van der Velden, Wijnand J. C., Stutsman, Cynthia, Cardona, Guemalli R., Urva, Shweta, Emmerson, Paul J., Holst, Jens J., D'Alessio, David A., Coghlan, Matthew P., Rosenkilde, Mette M., Campbell, Jonathan E., Sloop, Kyle W.
المصدر: Willard , F S , Douros , J D , Gabe , M , Showalter , A D , Wainscott , D B , Suter , T M , Capozzi , M E , van der Velden , W J C , Stutsman , C , Cardona , G R , Urva , S , Emmerson , P J , Holst , J J , D'Alessio , D A , Coghlan , M P , Rosenkilde , M M , Campbell , J E & Sloop , K W 2020 , ' Tirzepatide is an imbalanced and biased dual ....
مصطلحات موضوعية: GLUCAGON-LIKE PEPTIDE-1, DEPENDENT INSULINOTROPIC POLYPEPTIDE, SERUM-PROTEIN BINDING, IN-VITRO, DULAGLUTIDE, AFFINITY, PHARMACOLOGY, SEMAGLUTIDE, ACTIVATION, INHIBITORS
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1172/jci.insight.140532Test
https://curis.ku.dk/portal/da/publications/tirzepatide-is-an-imbalanced-and-biased-dual-gip-and-glp1-receptor-agonistTest(b80e9b5a-b66f-40b9-b147-1499515f8ed3).html
https://curis.ku.dk/ws/files/251737736/140532.2_20200828161921_covered_253bed37ca4c1ab43d105aefdf7b5536.pdfTest -
3دورية أكاديمية
المؤلفون: Vukajlovic, Tanja, Sailer, Clara O, Asmar, Ali, Jensen, Boye L, Vogt, Deborah R, Christ-Crain, Mirjam, Winzeler, Bettina
المصدر: Vukajlovic , T , Sailer , C O , Asmar , A , Jensen , B L , Vogt , D R , Christ-Crain , M & Winzeler , B 2022 , ' Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants ' , The Journal of Clinical Endocrinology & Metabolism , vol. 107 , no. 6 , pp. e2581-e2589 . https://doi.org/10.1210/clinem/dgac063Test
مصطلحات موضوعية: Aldosterone/pharmacology, Angiotensin II, Diabetes Mellitus, Type 2, Double-Blind Method, Glucagon-Like Peptide 1/pharmacology, Glucagon-Like Peptide-1 Receptor/agonists, Humans, Hypoglycemic Agents/therapeutic use, Immunoglobulin Fc Fragments, Natriuresis, Recombinant Fusion Proteins/pharmacology, Renin, GLP-1, RAAS, dulaglutide, MR-proANP
العلاقة: https://portal.findresearcher.sdu.dk/da/publications/281c4455-3435-4271-88ee-fa8708e0ad9aTest
الإتاحة: https://doi.org/10.1210/clinem/dgac063Test
https://portal.findresearcher.sdu.dk/da/publications/281c4455-3435-4271-88ee-fa8708e0ad9aTest